{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_5184", "batch_size": 200, "batch_pos": 15, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain any high-potency verbs, potent metaphors, critical alert phrases, superlatives + harm nouns, or intensifiers + harm nouns.", "method": "llm_batch", "batch_id": "batch_2_4800", "batch_size": 200, "batch_pos": 3, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "The segment describes a deal/contract.", "method": "llm_batch", "batch_id": "batch_3_11768", "batch_size": 200, "batch_pos": 142, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_15088", "batch_size": 200, "batch_pos": 136, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Reports details of the deal; no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_9664", "batch_size": 200, "batch_pos": 132, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a Q6 minimiser ('only', 'just', 'merely', etc.) combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_11032", "batch_size": 200, "batch_pos": 104, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_6924", "batch_size": 200, "batch_pos": 82, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "The segment describes securing resources/preparedness measure ('secures up to 665,000 doses', 'includes an option for a further 40 million vaccines').", "method": "llm_batch", "batch_id": "batch_8_18872", "batch_size": 200, "batch_pos": 150, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
